Fujita Group


Original Articles

Barker, R. A., Boer, G. J., Cattaneo, E., Charo, R. A., Lopes, S., Cong, Y. L., Fujita, M., Goldman, S., Hermeren, G., Hyun, I., Lisgo, S., Rosser, A. E., Anthony, E., & Lindvall, O. (2022). The need for a standard for informed consent for collection of human fetal material. Stem Cell Reports, 17(6), 1245-1247. doi:10.1016/j.stemcr.2022.05.013

Fujita, M., Hatta, T., & Ide, K. (2022). Current status of cell-based interventions in Japan. Cell Stem Cell, 29(9), 1294-1297. doi:10.1016/j.stem.2022.08.003

Hatta, T., Ide, K., Fujita, M., & Ikka, T. (2022). Financial risks posed by unproven cell interventions: Estimation of refunds from medical expense deductions in Japan. Stem Cell Reports, 17(5), 1016-1018. doi:10.1016/j.stemcr.2022.03.015

Murata, M., Kawabe, K., Hatta, T., Maeda, S., & Fujita, M. (2022). Current status of umbilical cord blood storage and provision to private biobanks by institutions handling childbirth in Japan. Bmc Medical Ethics, 23(1). doi:10.1186/s12910-022-00830-8

Sato, H., Fujita, M., Tsuchiya, A., Hatta, T., Mori, K., Nakazawa, E., Takimoto, Y., & Akabayashi, A. (2022). Disclosing a diagnosis of autism spectrum disorder without intellectual disability to pediatric patients in Japan in early diagnostic stages and associated factors: a cross-sectional study. Biopsychosocial Medicine, 16(1). doi:10.1186/s13030-022-00247-0


Original Papers

Ide, K., Koshiba, H., Hawke, P., & Fujita, M. (2021). Guidelines Are Urgently Needed for the Use of Preprints as a Source of Information. Journal of Epidemiology, 31(1). 97-99.

Sawai, T., Hayashi, Y., Niikawa, T., Shepherd, J., Thomas, E., Lee, T. L., Erler, A., Watanabe, M., & Sakaguchi, H. (2021). Mapping the Ethical Issues of Brain Organoid Research and Application. AJOB Neurosci, 1-14.


Original Papers

Sawai, T., Minakawa, T., Pugh, J., Akatsuka, K.,Yamashita, J. K., & Fujita, M. (2020). The moral status of humanembryo-like structures: potentiality matters? The moral status of humansynthetic embryos. Embo Reports, 21(8).

Crane, A. T., Shen, F. X., Brown, J. L., Cormack, W.,Ruiz-Estevez, M., Voth, J. P., Sawai, T., Hatta, T., Fujita, M., &Low, W. C. (2020). The American Public Is Ready to Accept Human-Animal ChimeraResearch. Stem Cell Reports, 15(4), 804-810.

Akatsuka, K., Sasaki-Honda, M., & Sawai, T.(2020). Ethical Framework for Next-Generation Genome and Epigenome Editing. AmJ Bioeth, 20(8), 32-36.


Original Papers

Sawai, T., Hatta, T., & Fujita, M. (2019). Japan Significantly Relaxes Its Human-Animal Chimeric Embryo Research Regulations. Cell Stem Cell, 24(4), 513-514.

Sawai, T., Sakaguchi, H., Thomas, E., Takahashi, J., & Fujita, M. (2019). The Ethics of Cerebral Organoid Research: Being Conscious of Consciousness. StemCell Reports, 13(3), 440-447.

Ozeki-Hayashi, R., Fujita, M., Tsuchiya, A., Hatta, T., Nakazawa, E., Takimoto, Y., &Akabayashi, A. (2019). Beliefs held by breast surgeons that impact the treatment decision process for advanced breast cancer patients: a qualitative study. Breast Cancer-Targets and Therapy, 11, 221-229.

Other Article

Fujita, M., & Tabuchi, K. (2019). A rebuttal to Akabayashi and colleagues’ criticisms of the iPSC stock project. J Med Ethics, 45(7), 476-477. https://